Polysulfonium: Unveiling a Bioactive Polymer to Induce Immunogenic Cell Death for Anticancer Therapy

Area of Science:

• Biomaterials Science
• Cancer Immunology
• Polymer Chemistry

Background:

• Developing novel therapeutic agents for cancer treatment is crucial.
• Immunogenic cell death (ICD) is a promising strategy to stimulate anti-tumor immune responses.
• Cationic polymers offer potential for targeted drug delivery and therapeutic applications.

Purpose of the Study:

• To synthesize and characterize a novel bioactive polymer containing sulfonium moieties.
• To investigate the potential of this polymer in inducing immunogenic cell death (ICD) for anticancer therapy.
• To evaluate the polymer's efficacy, selectivity, and immune memory effects in preclinical cancer models.

Main Methods:

• Synthesis and characterization of a novel polysulfonium polymer.
• In vitro assessment of cytotoxicity and mechanism of action (membrane disruption).
• In vivo evaluation of anti-tumor efficacy, immune memory, and metastasis suppression in B16-F10 melanoma models.

Main Results:

• The optimized polysulfonium demonstrated potent and selective anticancer activity.
• The polymer induced cancer cell death via a membrane-disrupting mechanism, triggering ICD.
• Significant suppression of primary tumor growth, recurrence, and metastasis was observed, alongside robust immune memory.

Conclusions:

• This study introduces a pioneering cationic polysulfonium with significant anticancer therapeutic potential.
• The polymer effectively induces ICD and establishes long-term anti-tumor immune memory.
• The findings highlight the promise of sulfonium-containing polymers for advanced cancer immunotherapy.